6-Chloro-5-(trifluoromethyl)pyridine-3-carboxylic acid, 95.0%, 5g

2- o -Tolyl-pyrrolidine oxalic acid salt, 95.0%, 1g

2-Bromoquinoline>98.0%(GC)(T)1g

7-Chloro-3-formylindole, 98.0%, 250mg

2'-(4-Fluorobenzyloxy)acetophenone, 99.0%, 100g

3-Amino-2,6-dichlorobenzonitrile, 97%, 250mg

(3-Methyloxetan-3-yl)methyl 4-methylbenzenesulfonate, 95.0%, 10g

1-p-Tolyl-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

1-(5-bromopyrimidin-2-yl)ethan-1-amine hydrochloride, 95%, 1g

Acide maléique, min 99 %, 500 g, emballage plastique.

Ulixertinib, 25mg

tert-Butyl 4-(quinazolin-4-ylamino)piperidine-1-carboxylate, 1g

6-chloro-3-propyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 95.0%, 250mg